FDA Inspection 1252735 — Innovative Blood Resources

Innovative Blood Resources — FEI 2177724

The FDA completed an inspection of Innovative Blood Resources on October 22, 2024 in Duluth, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
October 22, 2024
Fiscal Year
2025
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Duluth, MN (United States)